212 results on '"Zakeri K"'
Search Results
2. Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imaging
3. Pilot Randomized Clinical Trial of Geriatric Comanagement or Geriatric Guided Supportive Care for Older Patients with Head and Neck CancerReceiving Radiation and Chemotherapy
4. Taguchi-based Optimal Dry Electrode Design
5. Impact of Surveillance Imaging in Patients with HPV-Associated Oropharyngeal Carcinomas Treated with Definitive Radiation and Chemotherapy
6. Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016
7. Nomogram to Predict Risk of Early Mortality Following Definitive or Adjuvant Radiation and Systemic Therapy for Head and Neck Cancer
8. Probing Magnons by Spin-Polarized Electrons
9. Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology
10. Triggered GTV-Based Offline Adaptation for LINAC Head and Neck Radiotherapy
11. Physician Graded Toxicity Profiles and Survival Outcomes among Patients with Non-Metastatic Oropharyngeal Carcinoma Treated with Proton Therapy vs. Intensity-Modulated Radiation Therapy
12. Treatment Outcomes for Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer
13. Outcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers
14. Proton Therapy for Head/Neck Adenoid Cystic Carcinoma (ACC)
15. Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis
16. Long-Term Results of External Beam Radiation Therapy (RT) with or without Concurrent Chemotherapy in Loco-Regionally Advanced or Recurrent Differentiated Thyroid Cancer (DTC)
17. A Pilot Study Evaluating Selective Minimal Residual Disease Directed Adjuvant Radiation in Human Papilloma Virus Associated Oropharynx Carcinoma
18. Long-term Therapeutic and Functional Outcomes With Organ Preservation for T4 Larynx and Hypopharynx Cancers
19. Dose and Volume De-Escalation for Elective Nodal Regions in Patients With Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Curative-Intent Concurrent Chemoradiation (CCRT)
20. Oropharyngeal Cancer Early Outcomes and Challenges During the COVID-19 Pandemic
21. Iterative Approach for a Class of Fuzzy Volterra Integral Equations Using Block Pulse Functions.
22. Temperature-driven change of morphology and magnetic anisotropy of Fe monolayers on GaAs(001)
23. Probing Magnons by Spin-Polarized Electrons
24. Radiation Treatment Breaks: Are They Detrimental to Outcomes for Oropharyngeal Carcinoma Treated with Definitive Chemoradiation?
25. Effect Of Hormone Therapy Within Risk Groups Defined By Generalized Competing Event Model: Ancillary Analysis Of NRG Oncology’s RTOG 9408
26. Competing Risk Analysis to Address Selection Bias in Comparative Effectiveness Research
27. Proton Therapy for Non-Skull Base Head and Neck Adenoid Cystic Carcinoma
28. Long-Term Update of Proton Beam Re-Irradiation for Recurrent Head and Neck Cancer
29. Changing the Paradigm in HPV-Negative Oropharyngeal Cancer: Deintensification Based on Low Risk of Locoregional Relapse
30. Outcomes of Major Salivary Gland Tumors Treated with Proton Beam Radiation Therapy
31. Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience
32. The Impact of Physician Productivity Metrics and Patient Tumor Biology on Receipt of RT in Elderly Patients with ER+ T1N0 Breast Cancer in a Tertiary Cancer Center
33. Risk of Pelvic Fracture by Type of Radiation Therapy in Older Patients
34. Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC)
35. Assessment of Interrater Reliability for Comorbidity Indices in Determining Eligibility for Treatment Intensification in Head and Neck Cancer
36. Patterns of Care Among Elderly US Veterans Treated for Head and Neck Cancer with Radiation Therapy
37. Current Status of Radiation Oncology Research funded through the National Cancer Institute’s Small Business Innovation Research Program
38. Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC)
39. Prognostic Role of p16 in Non-oropharyngeal Head and Neck Cancer
40. A Web-Based Tool to Compare Comorbidity Models and Geriatric Risk-Assessment in Head and Neck Cancer Patients
41. Generalized Competing Event Regression to Stratify Head and Neck Cancer Patients: Secondary Analysis of NRG Oncology RTOG 9003, 0129, and 0522
42. 1052PD - Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC)
43. 'Optimism bias' in contemporary national clinical trial network phase III trials: are we improving?
44. Competing Event Models Reduce Clinical Trial Costs in Elderly Cancer Patients
45. Single Isocenter Frameless Volumetric Modulated Arc Radiosurgery for Multiple Intracranial Metastases
46. Long-term Risks of Radiation Therapy for Stage II/III Rectal Cancer
47. Competing Event Models Improve Risk Stratification of Elderly Breast Cancer Patients
48. Analysis of composite endpoints in gene expression studies in oncology
49. Population-Based Study of Comorbidity and Noncancer Mortality in Head-and-Neck Cancer
50. Comparison of Acute and Late GI and GU Toxicity Following Whole-pelvis Versus Prostate-only IMRT With Daily Image Guidance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.